NCAPG2 Maintains Cancer Stemness and Promotes Erlotinib Resistance in Lung Adenocarcinoma.
- Resource Type
- Article
- Source
Cancers . Sep2022, Vol. 14 Issue 18, pN.PAG-N.PAG. 19p.- Subject
- *
ADENOCARCINOMA
*LUNG cancer
*EPIDERMAL growth factor receptors
*ERLOTINIB
*PROTEIN-tyrosine kinase inhibitors
*GENOMES
*CELL lines
*DRUG resistance in cancer cells - Language
- ISSN
- 2072-6694